Dr. Netley Dsouza, MD

NPI: 1447299193
Total Payments
$15,850
2022 Payments
$386.67
Companies
48
Transactions
845
Medicare Patients
3,435
Medicare Billing
$178,997

Payment Breakdown by Category

Food & Beverage$14,220 (89.7%)
Other$981.23 (6.2%)
Consulting$611.67 (3.9%)
Education$37.09 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $14,220 825 89.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $901.67 6 5.7%
Consulting Fee $611.67 2 3.9%
Honoraria $79.56 1 0.5%
Education $37.09 11 0.2%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $2,251 181 $0 (2020)
Allergan, Inc. $1,892 63 $0 (2020)
PFIZER INC. $1,278 94 $0 (2020)
SANOFI-AVENTIS U.S. LLC $1,103 49 $0 (2021)
AstraZeneca Pharmaceuticals LP $1,080 26 $0 (2020)
GlaxoSmithKline, LLC. $1,054 39 $0 (2020)
Janssen Pharmaceuticals, Inc $771.23 51 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $523.17 35 $0 (2020)
Boston Scientific Corporation $505.55 24 $0 (2019)
Merck Sharp & Dohme Corporation $501.46 44 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2022 $386.67 1 C. R. Bard, Inc. & Subsidiaries ($386.67)
2021 $20.00 1 SANOFI-AVENTIS U.S. LLC ($20.00)
2020 $2,221 121 GlaxoSmithKline, LLC. ($280.66)
2019 $3,764 187 Allergan Inc. ($628.99)
2018 $3,320 224 Novo Nordisk Inc ($662.71)
2017 $6,138 311 Allergan Inc. ($802.99)

All Payment Transactions

845 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
08/01/2022 C. R. Bard, Inc. & Subsidiaries Consulting Fee Cash or cash equivalent $386.67 General
05/12/2021 SANOFI-AVENTIS U.S. LLC SOLIQUA 100/33 (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $20.00 General
Category: Endocrine & Metabolic Diseases
11/23/2020 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT Food and Beverage In-kind items and services $12.01 General
Category: RESPIRATORY
11/18/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $8.84 General
Category: Diabetes
11/16/2020 PFIZER INC. CHANTIX (Drug), EUCRISA, COLOGUARD Food and Beverage In-kind items and services $12.31 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
11/04/2020 Abbott Laboratories Proclaim Family of SCS IPGs (Device) Food and Beverage In-kind items and services $22.74 General
Category: Cardiac Arrhythmias and Heart Failure
10/30/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $9.86 General
Category: Diabetes
10/29/2020 Novo Nordisk Inc RYBELSUS (Drug) Food and Beverage In-kind items and services $74.65 General
Category: Diabetes
10/23/2020 Amgen Inc. Aimovig (Biological), Otezla, Repatha Food and Beverage In-kind items and services $20.96 General
Category: Neuroscience
10/20/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $6.40 General
Category: Diabetes
10/16/2020 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $18.50 General
Category: Neuroscience
10/13/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $5.47 General
Category: Diabetes
10/10/2020 Lilly USA, LLC TRULICITY (Drug), JARDIANCE Food and Beverage In-kind items and services $12.10 General
Category: Diabetes
10/06/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $6.57 General
Category: Diabetes
10/02/2020 Vanda Pharmaceuticals Inc. HETLIOZ (Drug) Food and Beverage In-kind items and services $14.27 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
09/30/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.21 General
Category: GASTROENTEROLOGY
09/29/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $5.56 General
Category: Diabetes
09/22/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $8.74 General
Category: Diabetes
09/18/2020 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT Food and Beverage In-kind items and services $11.62 General
Category: RESPIRATORY
09/16/2020 PFIZER INC. PREVNAR 13 (Biological) Food and Beverage In-kind items and services $0.36 General
Category: VACCINES
09/15/2020 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $71.18 General
Category: RESPIRATORY
09/14/2020 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $16.39 General
Category: Cardiovascular
09/11/2020 Merck Sharp & Dohme Corporation PNEUMOVAX 23 (Biological), GARDASIL 9 Food and Beverage In-kind items and services $15.96 General
Category: VACCINE
09/11/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $5.41 General
Category: Diabetes
09/09/2020 PFIZER INC. PREVNAR 13 (Biological) Food and Beverage In-kind items and services $11.69 General
Category: VACCINES

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 303 523 $96,324 $23,695
2022 6 318 433 $90,574 $22,966
2021 4 179 239 $39,823 $12,416
2020 42 2,635 5,632 $332,504 $119,919
Total Patients
3,435
Total Services
6,827
Medicare Billing
$178,997
Procedure Codes
57

All Medicare Procedures & Services

57 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 186 386 $70,941 $17,368 24.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 56 68 $8,358 $2,703 32.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 34 42 $11,731 $2,407 20.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 14 14 $4,920 $1,146 23.3%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2023 13 13 $374.00 $71.83 19.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 168 271 $51,111 $13,245 25.9%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 31 31 $13,857 $3,710 26.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 31 37 $10,475 $2,565 24.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 39 45 $5,481 $1,483 27.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 37 37 $5,402 $1,065 19.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 12 12 $4,248 $897.98 21.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 83 135 $23,757 $7,568 31.9%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 49 49 $7,292 $2,046 28.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 27 35 $3,938 $1,426 36.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 20 20 $4,836 $1,377 28.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 273 481 $102,453 $33,088 32.3%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 97 139 $39,893 $15,125 37.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 115 115 $26,680 $13,273 49.7%
77067 Mammography of both breasts Office 2020 46 46 $15,640 $6,256 40.0%
99496 Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge Office 2020 19 23 $10,580 $4,493 42.5%
80053 Blood test, comprehensive group of blood chemicals Office 2020 245 422 $23,210 $4,399 19.0%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2020 218 290 $10,150 $3,839 37.8%
84443 Blood test, thyroid stimulating hormone (tsh) Office 2020 189 226 $12,430 $3,734 30.0%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2020 58 58 $5,800 $3,538 61.0%
G0297 Low dose ct scan (ldct) for lung cancer screening Office 2020 14 14 $4,550 $3,298 72.5%

About Dr. Netley Dsouza, MD

Dr. Netley Dsouza, MD is a Family Medicine healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447299193.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Netley Dsouza, MD has received a total of $15,850 in payments from pharmaceutical and medical device companies, with $386.67 received in 2022. These payments were reported across 845 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($14,220).

As a Medicare-enrolled provider, Dsouza has provided services to 3,435 Medicare beneficiaries, totaling 6,827 services with total Medicare billing of $178,997. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Tucson, AZ
  • Active Since 06/06/2006
  • Last Updated 04/21/2008
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1447299193

Products in Payments

  • TOUJEO (Drug) $858.01
  • Tresiba (Drug) $728.60
  • VRAYLAR (Drug) $719.76
  • Victoza (Drug) $656.50
  • ELIQUIS (Drug) $637.39
  • Ozempic (Drug) $497.37
  • INVOKANA (Drug) $471.39
  • XIFAXAN (Drug) $456.30
  • TRELEGY ELLIPTA (Drug) $372.07
  • VIBERZI (Drug) $358.57
  • JARDIANCE (Drug) $349.95
  • JANUVIA (Drug) $318.59
  • FARXIGA (Drug) $313.84
  • BEXSERO (Biological) $312.88
  • Vascepa (Drug) $311.51
  • Trintellix (Drug) $300.08
  • SOLIQUA (Drug) $299.46
  • XARELTO (Drug) $293.82
  • SOLIQUA 100/33 (Biological) $259.60
  • BEVESPI AEROSPHERE (Drug) $259.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Tucson